for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AnGes Inc

4563.T

Latest Trade

706.00JPY

Change

10.00(+1.44%)

Volume

1,898,900

Today's Range

684.00

 - 

708.00

52 Week Range

303.00

 - 

1,350.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

AnGes says exercise of options

Nov 16(Reuters) - AnGes Inc <4563.T>:Says 19,500 units of its 33th series options were exercised to 1,950,000 shares of its common stock from Nov. 15 to Nov. 16.

AnGes says exercise of options

Nov 14(Reuters) - AnGes Inc <4563.T>:Says 21,500 units of its 33th series options were exercised to 2,150,000 shares of its common stock from Nov. 1 to Nov. 14.

AnGes says exercise of options

Oct 30(Reuters) - AnGes Inc <4563.T>:Says 16,300 units of its 33th series options were exercised to 1,630,000 shares of its common stock from Oct. 12 to Oct. 30.

AnGes says exercise of options

Aug 15(Reuters) - AnGes Inc <4563.T>:Says 24,911 units of its 31th series options were exercised to 2.5 million shares of its common stock from Aug. 1 to Aug. 15.

AnGes says exercise of options

July 31 (Reuters) - AnGes Inc <4563.T>:Says 13,372 units of its 31th series options were exercised to 1.3 million shares of its common stock from July 18 to July 31 .

AnGes says joint development with Vasomune Therapeutics

July 30(Reuters) - AnGes Inc <4563.T>:Says it signed contract for joint development of drugs used for acute respiratory insufficiency, with Canada biotechnology firm Vasomune Therapeutics Inc.

AnGes says exercise of options

July 17(Reuters) - AnGes Inc <4563.T>:Says 12,134 units of its 31th series options were exercised to 1.2 million shares of its common stock from July 1 to July 17 .

AnGes says exercise of options

May 31 (Reuters) - AnGes Inc <4563.T>:Says 16,267 units of its 31th series options were exercised to 1.6 million shares of its common stock from May 1 to May 31 .

AnGes submits application for marketing approval for HGF gene therapy

Jan 22 (Reuters) - AnGes Inc <4563.T> ::Says it submits application for marketing approval to Pharmaceuticals and Medical Devices Agency (PMDA) for HGF gene therapy for the treatment of critical limb ischemia (CLI).

Anges MG says exercise of options

June 12 (Reuters) - Anges MG Inc <4563.T>:* Says 20,000 units of its 29th series options were exercised to 2 million shares of its common stock from June 10 to June 12.* Says the shares were exercised at the price of 390 yen per share.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up